Jinjia Chang

998 total citations
31 papers, 740 citations indexed

About

Jinjia Chang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinjia Chang has authored 31 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinjia Chang's work include Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (6 papers) and MicroRNA in disease regulation (4 papers). Jinjia Chang is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (6 papers) and MicroRNA in disease regulation (4 papers). Jinjia Chang collaborates with scholars based in China, United States and Macao. Jinjia Chang's co-authors include Xinyang Liu, Zheng Wu, Wenhua Li, Jin Li, Xiaoxiao Ge, Ruixuan Geng, Wenbo Tang, Dan Huang, Congqi Dai and Zhe Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jinjia Chang

30 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinjia Chang China 15 430 284 279 161 72 31 740
Huawei Zou China 16 403 0.9× 322 1.1× 244 0.9× 163 1.0× 43 0.6× 36 710
Huili Chu China 12 442 1.0× 244 0.9× 276 1.0× 187 1.2× 65 0.9× 15 710
Yangfan Lv China 16 583 1.4× 359 1.3× 205 0.7× 130 0.8× 72 1.0× 31 892
Jeanie Wu Singapore 13 552 1.3× 258 0.9× 218 0.8× 149 0.9× 76 1.1× 14 904
Linquan Wu China 15 460 1.1× 311 1.1× 167 0.6× 144 0.9× 77 1.1× 34 714
Wenxing Qin China 17 437 1.0× 283 1.0× 171 0.6× 95 0.6× 95 1.3× 30 780
Yingrong Lai China 17 727 1.7× 449 1.6× 298 1.1× 235 1.5× 67 0.9× 31 1.1k
Ming Quan China 18 584 1.4× 264 0.9× 200 0.7× 101 0.6× 59 0.8× 37 799
Liang Jin China 15 344 0.8× 413 1.5× 342 1.2× 166 1.0× 44 0.6× 32 822
Cuiju Tang China 14 382 0.9× 178 0.6× 340 1.2× 240 1.5× 96 1.3× 47 853

Countries citing papers authored by Jinjia Chang

Since Specialization
Citations

This map shows the geographic impact of Jinjia Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjia Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjia Chang more than expected).

Fields of papers citing papers by Jinjia Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinjia Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjia Chang. The network helps show where Jinjia Chang may publish in the future.

Co-authorship network of co-authors of Jinjia Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinjia Chang. A scholar is included among the top collaborators of Jinjia Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinjia Chang. Jinjia Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhuang, Tao, Jinjia Chang, Yanping Zhou, et al.. (2023). A2AR-mediated lymphangiogenesis via VEGFR2 signaling prevents salt-sensitive hypertension. European Heart Journal. 44(29). 2730–2742. 16 indexed citations
3.
Xu, Midie, Jinjia Chang, Wenfeng Wang, et al.. (2022). Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy. Frontiers in Immunology. 13. 934083–934083. 12 indexed citations
4.
Ni, Shujuan, Xin Wang, Jinjia Chang, et al.. (2022). Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population. Frontiers in Oncology. 12. 842787–842787. 7 indexed citations
5.
Chang, Jinjia, Midie Xu, Chenchen Wang, et al.. (2022). Dual HER2 Targeted Therapy With Pyrotinib and Trastuzumab in Refractory HER2 Positive Metastatic Colorectal Cancer: A Result From HER2-FUSCC-G Study. Clinical Colorectal Cancer. 21(4). 347–353. 29 indexed citations
6.
Chang, Jinjia, Xiaoyu Wang, Wei Zhang, et al.. (2022). Comprehensive molecular characterization and identification of prognostic signature in stomach adenocarcinoma on the basis of energy-metabolism-related genes. World Journal of Gastrointestinal Oncology. 14(2). 478–497. 7 indexed citations
7.
Zhao, Zhenxiong, Yanqiu Zhang, Hui‐Chuan Sun, et al.. (2022). Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K/Akt signaling. Acta Pharmacologica Sinica. 44(1). 178–188. 38 indexed citations
8.
Wang, Chenchen, Mingzhu Huang, Qirong Geng, et al.. (2021). Apatinib for patients with metastatic biliary tract carcinoma refractory to standard chemotherapy: results from an investigator-initiated, open-label, single-arm, exploratory phase II study. Therapeutic Advances in Medical Oncology. 13. 4277451079–4277451079. 2 indexed citations
9.
Xue, Kai, Jichuan Wu, Ran Li, et al.. (2021). Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma. Cell Death and Disease. 12(10). 900–900. 18 indexed citations
10.
Chang, Jinjia, Wen Zhang, Dan Zhu, et al.. (2020). <p>Tumor Response to Irinotecan is Associated with IL-10 Expression Level in Metastatic Colorectal Cancer-Results from mCRC Biomarker Study</p>. OncoTargets and Therapy. Volume 13. 11819–11826. 2 indexed citations
11.
Li, Wenhua, Jingbo Qie, Yao Zhang, & Jinjia Chang. (2020). Spatiotemporal Changes in Checkpoint Molecule Expression. Advances in experimental medicine and biology. 1248. 167–200. 3 indexed citations
12.
Huang, Mingzhu, Xiaoying Zhao, Siyuan Chen, et al.. (2020). Severe loss of visceral fat and skeletal muscle after chemotherapy predicts poor prognosis in metastatic gastric cancer patients without gastrectomy. Journal of Cancer. 11(11). 3310–3317. 14 indexed citations
13.
14.
Li, Wenhua, Jinjia Chang, Junjie Peng, et al.. (2017). Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer. Oncotarget. 8(22). 35783–35791. 22 indexed citations
15.
Kuang, Meng, et al.. (2016). Glutathione S-transferase P1 rs1695 A>G polymorphism and breast cancer risk: evidence from a meta-analysis. Genetics and Molecular Research. 15(2). 8 indexed citations
16.
Zhang, Zhe, Jiping Wang, Dongmei Ji, et al.. (2014). Functional Genetic Approach Identifies MET, HER3, IGF1R, INSR Pathways as Determinants of Lapatinib Unresponsiveness in HER2-Positive Gastric Cancer. Clinical Cancer Research. 20(17). 4559–4573. 59 indexed citations
17.
Chang, Jinjia, Xinyang Liu, Shanshan Wang, et al.. (2014). Prognostic Value of FGFR Gene Amplification in Patients with Different Types of Cancer: A Systematic Review and Meta-Analysis. PLoS ONE. 9(8). e105524–e105524. 45 indexed citations
18.
Liu, Xinyang, Zhichao Wang, Xiaowei Zhang, et al.. (2014). MUC1 gene polymorphism rs4072037 and susceptibility to gastric cancer: a meta-analysis. SpringerPlus. 3(1). 599–599. 10 indexed citations
19.
20.
Chang, Jinjia & Weimin Fan. (2013). Endocrine Therapy Resistance: Current Status, Possible Mechanisms and Overcoming Strategies. Anti-Cancer Agents in Medicinal Chemistry. 13(3). 464–475. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huawei Zou Breakdown of academic impact, for papers by Huili Chu Breakdown of academic impact, for papers by Yangfan Lv Breakdown of academic impact, for papers by Jeanie Wu Breakdown of academic impact, for papers by Linquan Wu Breakdown of academic impact, for papers by Wenxing Qin Breakdown of academic impact, for papers by Yingrong Lai Breakdown of academic impact, for papers by Ming Quan Breakdown of academic impact, for papers by Liang Jin Breakdown of academic impact, for papers by Cuiju Tang
Rankless by CCL
2026